GCL
HZNP

Glazer Capital LLC’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Glazer Capital LLC’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,000
Closed -$45K – 213
2023
Q3 		$45K Buy
+1,000
New +$107K ﹤0.01% 157

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Glazer Capital LLC's HZNP Position: Q4 2023 in Review

Glazer Capital LLC sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 1,002,282 shares — an estimated $116M sold.

Glazer Capital LLC first reported a position in HZNP in Q4 2022 and held it in 2 quarters. The position peaked at $116M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Glazer Capital LLC reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Glazer Capital LLC sold 1,002,282 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $116M.
  • Glazer Capital LLC first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022 and held it in 2 quarters.
  • Glazer Capital LLC's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $116M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Glazer Capital LLC's 13F filing for Q4 2023, filed 14 Feb 2024.